Stanford Medicine
Palo Alto, California, 94304, United States
Location status: Recruiting
NCT Number: NCT06329375
This study seeks to address the multifaceted challenges posed by food disparities and their negative consequences on health outcomes, via a comprehensive community health intervention program. Study objectives include:
1. To describe the social-demographic and clinical factors associated with food insecurity in the hospitalized diabetic population. 2. To design, implement and evaluate a nutrition program targeting the hospitalized diabetic population. The investigators will prospectively randomize the target population into either a nutrition program (Intervention), or state-of-art standard of care (SOC) in a 4:1 ratio. Participants in the intervention group will be provided the following two resources in addition to SOC: 1) Enhanced access to nutritious food (twice daily meal delivery up to 90 days post-discharge) 2) Education at discharge and continuing outreach to enhance knowledge for better diet and food options. 3. To enhance community engagement and develop a systematic implementation plan for long-term roll-out of the nutrition program.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Palo Alto, California, 94304, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Nutrition program with twice daily meal delivery up to 90 days post-discharge and food and diet education at discharge.
Time frame: 60 days from discharge
Primary outcome is whether the participant had food insecurity in the past 30 days, measured at 60-days post initial discharge by the Food Insecurity Reduction and Strategy Team (FIRST) Survey Instrument questionnaire.
a. Never true, Sometimes true, Often true, Patient refused
Time frame: 30-, and 90- days from discharge
The secondary outcome is whether the participant had food insecurity in the past 30 days, measured at 30-days and 90-days post initial discharge by the Food Insecurity Reduction and Strategy Team (FIRST) Survey Instrument questionnaire:
a. Never true, Sometimes true, Often true, Patient refused
Time frame: 30-,60-, and 90- days from discharge
Feeling overwhelmed by the demands of living with Diabetes measured using ordinal scale with range 1-6.
Time frame: 30-,60-, and 90- days from discharge
Whether ever having a low blood sugar (low glucose or hypoglycemic) reaction in the past 4 weeks and number of times having a low blood sugar (low glucose or hypoglycemic) reaction in the past 4 weeks. (ordinal scale: 0, 1-3, 4-7, 8+)
Time frame: 30-,60-, and 90- days from discharge
Proportion of participants who missed their recommended diabetes medication in the past 7 days at least once and the mean number of days that the medication was missed in the past 7 days, measured using measured by participant self-report during survey response collection at 30-,60-, and 90-days post-discharge.
Time frame: 30-,60-, and 90- days from discharge
Proportion of participants having overnight hospitalizations in the past 30 days and mean number of nights with overnight hospitalizations in the past 30 days measured by participant self-report during survey response collection at 30-,60-, and 90-days post-discharge.
Contact information is provided by the study sponsor or research team.
Stanford University
Other
Acronym: FIRST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07474376
Autoimmune Diseases, Diabetes Mellitus
Atlanta, Georgia, United States
View Trial DetailsNCT07386340
Autoimmune Diseases, Diabetes Mellitus
Escondido, California, United States
View Trial DetailsNCT06945406
Autoimmune Diseases, Diabetes Mellitus
Neuss, Germany
View Trial DetailsNCT06549023
Autoimmune Diseases, Cardiovascular Diseases
Mölndal, Sweden
View Trial Details